Sensory-Selective Local Anesthetic Compounds for Motor-Sparing Blockade

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing local anesthetics cause both sensory and motor nerve blockages, leading to numbness and paralysis, which is undesirable in certain medical and surgical procedures where selective sensory nerve blockade is needed.

Innovation Solution

Development of compounds and compositions that provide selective sensory nerve blockade by administering compounds of Formula (I), (II), or (III), which selectively target sensory nerves while preserving motor and autonomic responses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional local anesthetics are administered to block pain signals, then sensory nerve blockade is achieved, but motor nerve blockade also occurs causing numbness and paralysis

Engineering Contradiction:
Improvesensory nerve blockade effectivenessVSAvoidmotor nerve blockade side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by developing compounds with selective affinity for sensory nerve channels versus motor nerve channels. The chemical structures (Formula I, II, III) are designed to interact preferentially with sensory nerve sodium channels, creating a localized effect that blocks pain signals while leaving motor nerve function intact. This selectivity in molecular interaction achieves the desired local quality difference between sensory and motor nerve blockade.

Inventive Principle:
Principle #3Local quality

2Reliability

If local anesthetics are used to achieve complete nerve blockade, then all nerve signals are blocked, but motor function and autonomic responses are lost

Engineering Contradiction:
Improvepain blockade effectivenessVSAvoidpreservation of motor and autonomic function
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies segmentation by separating the blockade effect into selective sensory nerve inhibition while preserving motor and autonomic nerve function. The compounds are designed to segment their pharmacological action, targeting specific sensory nerve subtypes (such as A-delta and C fibers) while leaving motor nerves and autonomic nerves unaffected. This segmented approach allows pain blockade without loss of motor control or autonomic regulation.

Inventive Principle:
Principle #1Segmentation

3Object-affected harmful factors

If conventional anesthetics block all nerve conduction, then pain transmission is prevented, but sensation and motor response are both lost

Engineering Contradiction:
Improvepain transmission blockadeVSAvoidnumbness and paralysis
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent applies parameter changes by modifying the chemical parameters of local anesthetic compounds to achieve selective nerve blockade. The molecular structures (Formula I, II, III) incorporate specific substituents and functional groups that alter the compounds' affinity for different nerve channel types. By changing these chemical parameters, the anesthetics achieve selective binding to sensory nerve channels at lower concentrations, blocking pain signals without reaching the threshold for motor nerve blockade.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12454509B2Local anesthetics with selective-sensory nerve blockade
Publication Date: 2025.10.28 CHILDRENS MEDICAL CENT CORP
  • US12454509B2 patent drawing
  • US12454509B2 patent drawing
  • US12454509B2 patent drawing

AI summary

Provided herein are compounds that are local anesthetics and useful for inducing selective sensory nerve blockade. Also provided are pharmaceutical compositions and kits comprising the compounds, and methods of inducing selective sensory nerve blockade by administering the compounds and/or compositions to a subject.